Synaptogenix Inc (SNPX)

[InTheTrenches]

Just a guess, but I think this CTO has to do with the contract manufacturing agreement for synthetic Bryostatin OR possibly an extension of our agreement to use Bryostatin in neurological disorders.

Why? Scanning this document:

https://media2.mofo.com/documents/faq-confidential-treatment-requests.pdf

I see this statement:

"As a rule of thumb, the Staff has indicated that confidential treatment beyond the minimum term of an agreement usually is inappropriate, as the value of the information typically is associated with the effective period of an agreement."

The SEC document says the CTO expires in 10 years. So, it must be some type of long-term (10-year) agreement.

Perhaps the pricing and/or the royalty and/or the milestones we will pay to our contract manufacturer?

[ I just now see that Whatsupp confirmed this--thanks, Whatsupp! ]